Scholar Rock Holding buy Truist Financial Co.
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Scholar Rock Holding has seen massive gains of 65.00%. This prediction currently runs until 20.10.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Scholar Rock Holding | 3.093% | 3.093% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Scholar Rock Holding diskutieren
Stopped prediction by Truist_Financial_Co_ for Scholar Rock Holding
Scholar Rock Holding
25.11.24
25.11.25
26.11.25
Scholar Rock Holding
03.04.24
03.04.25
04.04.25
Scholar Rock Holding
25.03.24
25.03.25
26.03.25

